14 terminated. 14 Phase 3, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 14 | Terminated 14 |
| Phase 2 | 4 | Terminated 4 |
Follow Exercise: new trials by email Literature Review of Exercise trials Research Report on Exercise
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate LB1148 for Return of Bowel Function in Subjects Undergoing Bowel Resection LB1148, Placebo - Ileus, Gastro-Intestinal Disorder | Phase 3 | Terminated | Palisade Bio | 23 | 2022-06-28 | 2024-06-13 |
| A Phase 2/3 Study to Evaluate FP-025 in Patients With Severe to Critical COVID 19 FP-025 100 mg, FP-025 300 mg, Placebo - Severe to Critical COVID 19 With Associated ARDS | Phase 2 / Phase 3 | Terminated | Foresee Pharmaceuticals Co., Ltd. | 90 | 2021-04-06 | 2024-01-05 |
| Phase 2/3 Study to Evaluate PK, Safety & Efficacy of INM004 in STEC Positive Pediatric Patients for Prevention of HUS INM004, Placebo - Bloody Diarrhea, STEC, Unspecified | Phase 2 / Phase 3 | Terminated | Inmunova S.A. | 11 | 2019-07-17 | 2023-07-19 |
| Physical Activity in Renal Disease (PAIRED): The Effect on Hypertension Exercise, Enhanced usual care - Chronic Kidney Diseases | Phase 3 | Terminated | University of Alberta | 44 | 2018-11-21 | 2021-04-30 |
| Adjunctive Vitamin D in the Treatment of Non-remitted Depression Active, Placebo - Depression | Phase 3 | Terminated | START Clinic for Mood and Anxiety Disorders | 9 | 2013-12-01 | 2017-10-02 |
| A Health Intervention to Prevent Depression Hepatitis C Patients Exercise, Health Education - Hepatitis C, Major Depressive Disorder | Phase 2 / Phase 3 | Terminated | University of Texas Southwestern Medical Center | 1 | 2013-06-01 | 2016-12-29 |
| Effect of Weight and Insulin Sensitivity on Reproductive Function in PCOS Metformin, Dietary Restriction, Exercise Training - Polycystic Ovary Syndrome | Phase 3 | Terminated | Pennington Biomedical Research Center | 32 | 2012-05-01 | 2022-03-15 |
| Efficacy of Exercise and Counseling Intervention on Relapse in Smoker With Depressive Disorders Exercise and counseling (for smoking cessation and physical activity) - Smoking Cessation, Depression | Phase 3 | Terminated | University Hospital, Montpellier | 70 | 2010-10-01 | 2016-06-01 |
| Effect of Exercise and Phytoestrogen on Bone, Metabolic Syndrome Criteria and Complaints of the Early Menopause exercise, exercise + cimicifuga racemosa, wellness control, placebo - Bone Diseases, Metabolic Syndrome X | Phase 3 | Terminated | University of Erlangen-Nürnberg Medical School | 126 | 2008-04-01 | 2015-05-28 |
| Japanese Study With Rimonabant in Obese Type 2 Diabetic Patients on Diet and Exercise Rimonabant, placebo (for Rimonabant), Diet and exercise - Obesity, Diabetes Mellitus Type 2 | Phase 3 | Terminated | Sanofi | 321 | 2007-04-01 | 2016-06-08 |
| Ritalin: Antiasthenic Effect of Methylphenidate (Ritalin) in Palliative Care in Cancer Patients methylphenidate, placebo comparator - Asthenia, Neoplasms | Phase 3 | Terminated | University Hospital, Grenoble | 39 | 2007-01-01 | 2009-12-07 |
| Effect of Exercise on Risk-factors of Elderly Women physical exercise, wellness - Atrophy | Phase 3 | Terminated | University of Erlangen-Nürnberg Medical School | 246 | 2006-01-01 | 2015-06-01 |
| Botox for Non-surgical Lateral Release in Patellofemoral Pain Botulinum toxin A + exercise, Placebo - Patellofemoral Pain Syndrome | Phase 3 | Terminated | Virginia Commonwealth University | 5 | 2005-05-01 | 2017-10-23 |
| Assessment of the Treatment of Severely Burned With Anabolic Agents on Clinical Outcomes, Recovery and Rehabilitation Stable Isotope Infusion Study, Collection of blood and tissues, Radiology testing: Dual-energy X-ray absorptiometry (DEXA), ultrasound, MRI - Burns | Phase 2 / Phase 3 | Terminated | The University of Texas Medical Branch, Galveston | 1126 | 2004-01-01 | 2019-11-29 |
Motor Activity (6) · Depression (3) · Diabetes Mellitus (2) · Asthenia (1) · Atrophy (1) · Body Weight (1) · Bone Diseases (1) · Burns (1) · Cardiovascular Diseases (1) · Coronary Disease (1) · Depressive Disorder (1) · Depressive Disorder, Major (1) · Diabetes Mellitus, Type 2 (1) · Digestive System Diseases (1) · Hemolytic-Uremic Syndrome (1)
University of Erlangen-Nürnberg Medical School (2) · Foresee Pharmaceuticals Co., Ltd. (1) · Inmunova S.A. (1) · Palisade Bio (1) · Pennington Biomedical Research Center (1) · START Clinic for Mood and Anxiety Disorders (1) · Sanofi (1) · The University of Texas Medical Branch, Galveston (1) · University Hospital, Grenoble (1) · University Hospital, Montpellier (1) · University of Alberta (1) · University of Texas Southwestern Medical Center (1) · Virginia Commonwealth University (1)
United States (6) · Canada (2) · France (2) · Germany (2) · Argentina (1) · Japan (1)
Chad D Rethorst, Ph.D. (1) · David N Herndon, MD (1) · Guillemette Laval, M.D., Ph.D. (1) · Leanne M Redman, PhD (1) · Michael Bebenek, MS (1) · Mitch Jones, MD (1) · Sheryl D Finucane, PhD, PT (1) · Stephanie Thompson, MD PhD (1) · Susan Shelby, Ph.D. (1) · Willi A Kalender, PhD (1) · Willi A Kalender, Professor, PhD (1) · Wolfgang Kemmler, PhD (1)
PMID 19734776, PMID 20101013, PMID 20171529, PMID 20881067, PMID 22463890, PMID 22606232, PMID 22895351, PMID 23150682, PMID 23303450, PMID 24009246, PMID 24298851, PMID 24655871, PMID 24824900, PMID 24918945, PMID 25211297, PMID 25514427, PMID 25807408, PMID 26683252, PMID 27171844, PMID 27433905, PMID 28240622, PMID 28323951, PMID 30377436, PMID 30736832, PMID 34219224, PMID 34611902, PMID 40277027
P50GM060338 (1), R00HD060762 (1)